Novo Nordisk (CPSE:NOVO B) Is Up 12.7% After Nationwide Launch Of Oral Wegovy Pill [Yahoo! Finance]
LifeMD, Inc. (LFMD)
Company Research
Source: Yahoo! Finance
once-daily option for chronic weight management and cardiovascular risk reduction alongside diet and exercise. By pairing the pill's phase 3 trial weight-loss performance with broad distribution partnerships such as Ro, LifeMD, Weight Watchers, GoodRx and NovoCare Pharmacy, the company is seeking to expand access for adults who prefer pills over injections and want authentic, FDA-approved GLP-1 treatments. We'll now examine how the first FDA-approved oral Wegovy pill and its broad telehealth rollout may influence Novo Nordisk's investment narrative. The latest GPUs need a type of rare earth metal called Neodymium and there are only 39 companies in the world exploring or producing it . Find the list for free. To own Novo Nordisk, you have to believe GLP-1 therapies remain a core global pillar in obesity and diabetes care, and that the company can defend pricing and volumes as access widens. The Wegovy oral launch directly touches the key near term catalyst of broader obesity pe
Show less
Read more
Impact Snapshot
Event Time:
LFMD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LFMD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LFMD alerts
High impacting LifeMD, Inc. news events
Weekly update
A roundup of the hottest topics
LFMD
News
- What The Recent Setbacks And Progress Mean For LifeMD's Story And Valuation [Yahoo! Finance]Yahoo! Finance
- LifeMD Announces Closing of $50 Million Revolving Credit Facility with Citizens Bank, N.A.GlobeNewswire
- LifeMD Expands Collaboration with Novo Nordisk as Recognized Telehealth Partner Offering Newly Approved Wegovy® Pill [Yahoo! Finance]Yahoo! Finance
- LifeMD Expands Collaboration with Novo Nordisk as Recognized Telehealth Partner Offering Newly Approved Wegovy® PillGlobeNewswire
- LifeMD, Inc. 8.875% CUM PFD A declares $0.5547 dividend [Seeking Alpha]Seeking Alpha
LFMD
Earnings
- 11/17/25 - Miss
LFMD
Sec Filings
- 1/6/26 - Form 8-K
- 12/11/25 - Form 4
- 11/24/25 - Form 144
- LFMD's page on the SEC website